Lilium tigrinum 200C (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Lilium tigrinum 200C drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Lilium tigrinum
SUBSTANCE NAME: LILIUM LANCIFOLIUM WHOLE FLOWERING
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-06-22
END MARKETING DATE: 0000-00-00


Lilium tigrinum 200C HUMAN OTC DRUG Details:

Item DescriptionLilium tigrinum 200C from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 200([hp_C]/1)
START MARKETING DATE: 2015-06-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-1107_19152436-8fe4-3412-e054-00144ff8d46c
PRODUCT NDC: 69152-1107
APPLICATION NUMBER:

Other LILIUM LANCIFOLIUM WHOLE FLOWERING Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Paramesh Banerji Life Sciences LLCLilium tigrinum 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncLILIUM TIGRINUM
Seroyal USALILIUM TIGRINUM